TP53 and B-cell chronic lymphocytic leukemia: Chapters from 3.1 to 3.4 are respectively focused on discussing the role of TP53 disruption, UM IGHV mutational status, NOTCH1 mutations and high CD49d expression as putative predictive markers in CLL.